19NOVEMBER 2026neutered pets, which can face increased obesity risks because of altered energy requirements and appetite.The range extends across different life stages and physiological requirements, from puppies and kittens to adult and senior animals, including specialised nutrition for neutered pets and breed-specific needs. Its Global Preventive Profile addresses areas including urinary and renal health, oral care, skin and coat health, digestive function, immunity, mobility, brain development, hydration and stool quality.The portfolio has now been strengthened further through the VETERINARY HPM Dietetic Range, which provides specialised clinical nutrition for pets with specific health conditions and is available through veterinary recommendation. In doing so, Virbac is positioning nutrition not as an adjunct to pet care, but as an integral component of preventive and therapeutic healthcare.Building Scientific Confidence into Every FormulationThe credibility of preventive nutrition ultimately depends on consistency, evidence and quality. Virbac manufactures VETERINARY HPM at its dedicated facility in Vauvert, France, under stringent quality and traceability controls. The facility is ISO 9001 and HACCP certified, while formulations comply with FEDIAF nutritional guidelines.The emphasis on quality extends from ingredient selection to palatability and nutrient absorption. Highly digestible ingredients and carefully selected functional components are incorporated to support nutritional utilisation, while recipes are developed to ensure acceptance and consistent feeding. The company's manufacturing approach also reflects its wider sustainability priorities, including the transition of its dry food portfolio towards 100 percent recyclable packaging.This combination of scientific development, manufacturing discipline and veterinary expertise is central to Virbac's broader proposition. Whether addressing livestock productivity, poultry vaccination, companion animal nutrition or preventive healthcare, the organisation is increasingly working across the complete animal health continuum.Preparing Virbac India for Its Next Growth StoryThe next phase of Virbac India's journey is being shaped by the same principles that have defined its first 20 years, while placing greater emphasis on innovation, regional collaboration and specialised capabilities. As Area Director for IMEA, Natesan is focused on strengthening India's contribution to the region while continuing to expand capabilities across pharmaceuticals, biologicals, nutrition and preventive healthcare.The integration of Globion as Virbac Biologicals is expected to further strengthen the company's biologicals platform, particularly in poultry vaccines, while continued investments in manufacturing and scientific capabilities will support the organisation's ability to respond to evolving market requirements. In companion animal healthcare, the expansion of evidence-based nutrition, including specialised dietetic solutions, reflects the growing convergence between prevention and treatment.For Virbac India, however, growth is not being defined purely by turnover, geographic reach or portfolio expansion. The larger objective is to deepen the ecosystem around animal health by working closely with veterinarians, farmers, pet parents, employees and partners. After two decades of building scale and capabilities in India, the company enters its next chapter with a foundation that combines global knowledge, local understanding and an increasingly broad preventive healthcare proposition.That makes the 20-year milestone more than a celebration of what Virbac India has achieved. It marks a transition from building the organisation to expanding the possibilities of what it can contribute to animal healthcare in India and across the wider IMEA region.
< Page 9 | Page 11 >